News from sound pharmaceuticals, inc

Feb 18, 2014, 09:00 ET

Sound Pharmaceuticals submits positive Phase 2 clinical trial data on SPI-1005 for the prevention and treatment of sensorineural hearing loss

Sound Pharmaceuticals (SPI) has submitted a scientific abstract for presentation at the American Academy of Otolaryngology-Head and Neck Surgery...

Nov 05, 2013, 11:09 ET

Sound Pharmaceuticals successfully completes its first Phase 2 clinical trial with SPI-1005 involving iPod® or noise induced hearing loss

Sound Pharmaceuticals (SPI) has successfully completed enrollment of its Phase 2 clinical trial with SPI-1005 at the University of Florida. This...

Dec 05, 2012, 13:58 ET

University of Florida begins iPod® trial with SPI-1005 to prevent hearing loss

 The University of Florida (UF) has started enrolling subjects in a new study testing the oral drug developed by Sound Pharmaceuticals, Inc....

Nov 28, 2012, 15:11 ET

Nobel Prize Winner Bruce Beutler joins Sound Pharmaceuticals

 Sound Pharmaceuticals, Inc. is honored to have Bruce A. Beutler, a recipient of the 2011 Nobel Prize in Physiology or Medicine for his...

Jun 06, 2011, 12:15 ET

Sound Pharmaceuticals Announces a New SPI-1005 Clinical Trial Involving Personal Music Players

Sound Pharmaceuticals (SPI) will begin recruiting a new clinical trial testing the oral drug SPI-1005 to prevent the hearing loss induced by loud...

Feb 24, 2011, 15:10 ET

UCLA and Sound Pharmaceuticals Identify a Key Hearing Regeneration Protein in the Human Inner Ear

In collaboration with scientists and clinicians from the University of California Los Angeles, scientists from Sound Pharmaceuticals have found...

Aug 19, 2009, 19:11 ET

Sound Pharmaceuticals Receives an Office of Naval Research Award for Its Hearing Loss Research and Development

Sound Pharmaceuticals (SPI) has received a $2.1 million research and development award from the Office of Naval Research, Science and Technology...

Aug 07, 2008, 01:00 ET

FDA Allows Phase 2 Study for Sound Pharmaceuticals' Novel Drug to Prevent Chemotherapy Induced Hearing Loss

SEATTLE, Aug. 7 /PRNewswire/ -- Sound Pharmaceuticals (SPI) has received FDA notification that it may proceed with its Phase II study to prevent...

Jul 23, 2008, 01:00 ET

Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer

SEATTLE, July 23 /PRNewswire/ -- Sound Pharmaceuticals (SPI) has filed an Investigational New Drug Application with the FDA for the clinical...

Jan 04, 2007, 00:00 ET

Sound Pharmaceuticals Announces the Successful Completion of its Phase I Clinical Trial for SPI-1005

SEATTLE, Jan. 4 /PRNewswire/ -- Sound Pharmaceuticals (SPI) has completed Phase I clinical testing of SPI-1005, an oral compound, under...

Jun 12, 2006, 01:00 ET

New Drug for Hearing Loss Enters Clinical Testing

SEATTLE, June 12 /PRNewswire/ -- Sound Pharmaceuticals initiates clinical testing of SPI-1005 for the prevention and treatment of noise induced...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets